Skip to content

Anemia in girls and effect of vajra vatak mandoor(Ayurveda compound) in its management

Study of Prevalence of Iron Deficiency Anemia in Adolescent Girls and Efficacy of Vajra Vatak Mandoor in Its Management

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/10/010037
Enrollment
100
Registered
2017-10-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Mild to moderate anemia

Interventions

Intervention1: Vajra vatak Mandoor , 500 mg in two divided doses daily for 8 weeks given with butter milk: Pandurogadhikar, Bhaishajya Ratnavali Control Intervention1: Iron folic acid tablets, 100 mg

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Adolescent girls aged between 12-15years. 2) Adolescent girls with iron deficiency anemia (Hb 8 gm-12 gm%). 3) Adolescent whose parents were willing to give consent for clinical trial.

Exclusion criteria

Exclusion criteria: 1) Adolescent girls suffering from major systemic illness necessitating long term treatment. 2) Adolescent girls with evidence of malignancy. 3) Adolescent girls with concurrent serious hepatic dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or renal dysfunction (defined as S. creatinine >1.2mg/dl) uncontrolled pulmonary dysfunction (asthmatic and COPD patients) 4) Co-morbidity like TB, UTI and bleeding disorders etc. 5) H/o hypersensitivity to any of the trial drug or their ingredients. 6) Adolescent girls who have completed participation in any other clinical trial during the past six months.

Design outcomes

Primary

MeasureTime frame
9.9% Improvement in hemoglobin level and other symptoms of iron deficiency anemia .Timepoint: at the 28th day, 56th day and after follow up period of 4 weeks

Secondary

MeasureTime frame
38.09% relief observed with extremely significant P value in loss of appetiteTimepoint: at the 28th day, 56th day and after follow up period of 4 weeks

Countries

India

Contacts

Public ContactDr Rashmi Pareek

National Institute of Ayurveda

rashmi.pareek007@gmail.com7891832811

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026